Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Am J Cancer Res

Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.

Published: June 2022

[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251675PMC

Publication Analysis

Top Keywords

erratum overcome
4
overcome trastuzumab
4
trastuzumab resistance
4
resistance breast
4
breast cancer
4
cancer anti-her2
4
anti-her2 chimeric
4
chimeric antigen
4
antigen receptor
4
receptor cells
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!